|
End-of-day quote
Bulgaria S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 3.280 EUR | +0.31% |
|
+6.49% | +130.25% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.28B 1.97B 1.77B 1.63B 1.48B 2.76B 187B 2.8B 19.52B 7.78B 98.1B 7.39B 7.23B 311B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.82B 2.29B 2.06B 1.9B 1.72B 3.22B 218B 3.26B 22.75B 9.06B 114B 8.61B 8.42B 363B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +0.31% | ||
| 1 week | +6.49% | ||
| Current month | +26.64% | ||
| 1 month | +26.64% | ||
| 3 months | +72.63% | ||
| 6 months | +92.94% | ||
| Current year | +130.25% |
| 1 week | 3.2 |  | 3.37 |
| 1 month | 2.49 | | 3.37 |
| Current year | 1.41 | | 3.37 |
| 1 year | 1.34 | | 3.37 |
| 3 years | 0.94 | | 3.37 |
| 5 years | 0.68 | | 3.37 |
| 10 years | 0.41 | | 3.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/9/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/9/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | +6.49% | +137.57% | +168.00% | 1.96B | |
| -0.11% | -4.16% | -40.03% | +0.97% | 15.09B | |
| +0.10% | -3.90% | -8.59% | -1.79% | 6.5B | |
| +0.81% | -0.64% | -16.72% | +1.52% | 6.38B | |
| -0.36% | -2.28% | -51.99% | -40.47% | 5.75B | |
| -14.44% | -25.66% | -17.58% | -37.54% | 5.28B | |
| -2.58% | -2.81% | -2.28% | -10.64% | 4.65B | |
| -0.42% | -5.09% | -13.01% | -20.45% | 3.17B | |
| -0.16% | +2.05% | +1.15% | -22.87% | 3.16B | |
| -4.44% | -10.93% | -42.24% | -18.73% | 3.14B | |
| Average | -2.10% | -5.24% | -5.37% | +1.80% | 5.51B | |
| Weighted average by Cap. | -1.81% | -6.04% | -19.41% | -6.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.15B 1.07B 965M 1.8B 122B 1.83B 12.74B 5.08B 64.04B 4.82B 4.72B 203B | 2.63B 1.58B 1.42B 1.31B 1.19B 2.22B 151B 2.25B 15.68B 6.25B 78.8B 5.93B 5.81B 250B |
| Net income | 77.85M 46.75M 41.95M 38.78M 35.12M 65.62M 4.45B 66.41M 464M 185M 2.33B 175M 172M 7.4B | 134M 80.19M 71.95M 66.52M 60.25M 113M 7.64B 114M 795M 317M 4B 301M 295M 12.69B |
| Net Debt | 444M 267M 239M 221M 200M 374M 25.41B 379M 2.65B 1.05B 13.3B 1B 980M 42.21B | 541M 325M 292M 270M 244M 456M 30.96B 462M 3.22B 1.28B 16.2B 1.22B 1.19B 51.43B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | €3.280 | +0.31% | 39,789 |
| 27/10/26 | €3.270 | -0.61% | 56,773 |
| 26/10/26 | €3.290 | -0.90% | 30,115 |
| 23/10/26 | €3.320 | +3.75% | 41,241 |
| 22/10/26 | €3.200 | +3.90% | 40,227 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
